Skip to main content
BIOX
NASDAQ Industrial Applications And Services

Major Shareholder Continues Selling Amidst Company Distress

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.41
Mkt Cap
$25.905M
52W Low
$0.347
52W High
$5.175
52W Position info
18% above low
Off High info
92% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

BIOX sits 18% above its 52-week low of $0.347 on light trading volume (0.4× avg).

Summary

Agriculture Investment Group Corp. and Granosur Holding Limited reported selling an additional 1.1 million shares of Bioceres Crop Solutions Corp. for approximately $462,672, further reducing their stake to 9.05%.


Key Events · Ownership and Investor Activity · BIOX

  • Major Shareholder Reduces Stake

    Agriculture Investment Group Corp. and Granosur Holding Limited sold 1,101,166 shares of Bioceres Crop Solutions Corp. between March 13 and March 20, 2026.

  • Significant Proceeds from Sales

    The sales generated approximately $462,672 in gross proceeds, with average prices declining from $0.53 to $0.36 per share during the period.

  • Ownership Decreases to 9.05%

    Following these transactions, the reporting persons' beneficial ownership decreased to 5,776,807 shares, representing 9.05% of the outstanding ordinary shares.

  • Sales Amidst Company Distress

    These dispositions occurred while the company faces a going concern warning and a Nasdaq delisting notice, reinforcing negative market sentiment.


Analysis · BIOX · Industrial Applications And Services

This Schedule 13D/A details continued significant selling by a major shareholder, Agriculture Investment Group Corp. and Granosur Holding Limited, who disposed of 1.1 million shares between March 13 and March 20, 2026. These sales, totaling approximately $462,672, represent a substantial portion of the company's market capitalization and occur amidst severe financial distress for Bioceres Crop Solutions, including a recent going concern warning and a Nasdaq delisting notice. The ongoing disposition by a key investor, even at declining prices, signals a lack of confidence and adds to the negative sentiment surrounding the company's future. This follows a previous 13D/A on March 13, which also reported significant sales.

At the time of this filing, BIOX was trading at $0.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $25.9M. The 52-week trading range was $0.35 to $5.18. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIOX - Latest Insights

BIOX
Jul 07, 2026, 7:08 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.3294
Real-time Price: $0.343 info
Change: +$0.0136 (+4%) info
Market Cap: $21.687M info
BIOX
Jun 22, 2026, 6:04 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.3726
Real-time Price: $0.343 info
Change: -$0.0296 (-8%) info
Market Cap: $21.687M info
BIOX
Jun 01, 2026, 5:16 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4837
Real-time Price: $0.343 info
Change: -$0.1407 (-29%) info
Market Cap: $21.687M info
BIOX
Jun 01, 2026, 10:16 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4338
Real-time Price: $0.343 info
Change: -$0.0908 (-21%) info
Market Cap: $21.687M info
BIOX
May 12, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.451
Real-time Price: $0.343 info
Change: -$0.108 (-24%) info
Market Cap: $21.687M info